Establishment of a prognostic nomogram for evaluating non-adjuvant therapy in patients with stage I to III esophageal cancer: a population-based studyGuanglei Zhang, Chunguang Wang, Yan Zhang et al.|Journal of Thoracic Disease|2025Cited by 0
Gilteritinib overcomes second‑generation TKIs resistance in ALK‑rearranged non‑small‑cell lung cancer by inhibiting PD‑L1 and CD8 co‑expressionHang Guo, Chunguang Wang, Jincheng Wang et al.|International Journal of Molecular Medicine|2026Cited by 0